Enzo Biochem

Enzo Biochem is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, we have concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of our technologies are applicable to the biomedical and pharmaceutical research markets, and we are further using these technologies as a platform for our entry into the clinical diagnostics market. Today, Enzo technologies and products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide. Additionally, Enzo's work in gene analysis has led to development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. In the course of our extensive research and development activities, we have built a significant patent position consisting of numerous pioneer patents and applications that encompass our core technologies. The business activities of Enzo Biochem are performed by the company's three wholly owned subsidiaries . . . Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Such activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics and the operation of a regional clinical reference laboratory through Enzo Clinical Labs. Enzo's vision of the importance of recombinant DNA technology as an informational source more than two decades ago has now become a major direction in modern medicine.

Contact Details: 527 Madison Avenue New York New York 10022 United States of America Tel: 212-583-0100 Fax: 516 755 5569 Email: WWW: www.enzobio.com/

Loading...

Press Releases on Enzo Biochem:
GeneNews partners with Enzo Clinical Labs to market ColonSentry(TM) in the U.S.	18th November, 2009	GeneNews Limited	- GeneNews licenses exclusive marketing rights for colorectal cancer blood test to Enzo for key states of New York and New Jersey - TORONTO, Nov. 18 /PRNewswire-FirstCall/ - GeneNews Limited (TSX:
Clinical Diagnostic Lab Testing Market to Grow Over 90% through 2017	14th April, 2009	Washington G-2 Reports	Washington G-2 Reports releases 2009 Laboratory market projections. NEWARK, N.J., April 14 /PRNewswire/ -- A new study from market research firm Washington G-2 Reports indicates that the clinical
Mergent, Inc. Announces Changes to the HealthShares(TM) Infectious Disease and HealthShares(TM) Composite Indexes	8th August, 2008	Mergent, Inc.	NEW YORK, Aug. 8 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares Exchange Traded Funds, today announced the
New Report from PharmaPlus: HIV Pipelines & Deals	1st December, 2003	Pharmaplus	New Report from PharmaPlus: HIV Pipelines & Deals  At the end of November 2003 the joint United Nations Program on HIV/AIDS and the World Health Organization presented

BioNews Results for Enzo Biochem:
Updates for SunLink (NYSE:SSY), Enzo Biochem Inc. (NYSE:ENZ), Pro-Pharmaceuticals (OTC:PRWP)	American Chronicle:  Nov 16 2009 12:50AM Matching: enzo biochem
Enzo Biochem Executive to Discuss Oral Immune Regulation Platform at Windhover TA Partnerships 2009 Conference	Freshnews.com:  Nov 13 2009 5:24PM Matching: enzo biochem
Enzo Biochem to Present at Lazard Capital Markets 6th Annual Healthcare Conference	Pharma Live:  Nov 13 2009 10:14PM Matching: enzo biochem
Enzo Biochem Executive to Discuss Oral Immune Regulation Platform at Windhover TA Partnerships 2009 Conference	Pharma Live:  Nov 13 2009 9:37PM Matching: enzo biochem
Enzo Biochem Executive to Discuss Oral Immune Regulation Platform at Windhover TA Partnerships 2009 Conference	Genetic Engineering News:  Nov 13 2009 4:50PM Matching: enzo biochem
Promote your company here: BioNewsCast - Press Release Distribution	→View more Enzo Biochem news.

Enzo Biochem Patents:
US Patent No.	Title
7608274	Therapeutic processes and useful compositions therefor
4952685	Detectable molecules, method of preparation and use
4943523	Detectable molecules, method of preparation and use
4900659	Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group
4894325	Hybridization method for the detection of genetic material
→View more Enzo Biochem patents.

Enzo Biochem (ENZ) Financial information Links from Barchart
ENZ Quote from from Barchart.com
ENZ Chart from from Barchart.com
ENZ Profile from from Barchart.com
ENZ Opinion from from Barchart.com
→View more Enzo Biochem finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 998 times since April 2007, the link to the organisation's website has been followed 157 times

Recent Search Terms used to find this page: enzo clinical labs | enzo pha | enzo biochem company profile | ENZO BIOCHEM INC Financial and Strategic Analysis Review | enzo biochem | using these technologies as a platform for our entry | patents enzobiochem | .

Search for more companies in New York

Search for more companies in New York

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Enzo Biochem